• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Remibrutinib Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5755445

Remibrutinib inhibits BTK activity with an IC50 value of 0.023uM in blood. Remibrutinib is an effective and orally active Bruton tyrosine kinase inhibitor (IC50: 1nM). Remibrutinib has the potential for Chronic urticaria (CU) treatment. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Remibrutinib, Inhibitor
Full Product Name
Remibrutinib
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
507.53
Solubility
DMSO: 125mg/mL (246.29mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C27H27F2N5O3
SMILES
O=C(NC1=CC(F)=CC(C2=NC=NC(N)=C2OCCN(C)C(C=C)=O)=C1C)C3=CC=C(C4CC4)C=C3F
CAS Number
1787294-07-8
Target & IC50
BTK: ic50 1nM

Product References and Citations for Remibrutinib, inhibitor

Daniela Angst, et al. Novel amino pyrimidine derivatives. Patent WO2015079417A1.
Daniela Angst, et al. Novel amino pyrimidine derivatives. Patent WO2015079417A1.
Kolkhir P, et al. New treatment, for chronic urticaria. Ann Allergy Asthma Immunol. 2019 Aug 23.
Kolkhir P, et al. New treatment, for chronic urticaria. Ann Allergy Asthma Immunol. 2019 Aug 23.

Other Notes

Small volumes of Remibrutinib, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Remibrutinib purchase

MBS5755445 is an inhibitor targeting Remibrutinib.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000